Depemokimab twice per year reduces exacerbations (NNT = 167); only minimally reduces severe exacerbations (NNT = 1428) (SWIFT-1 and SWIFT-2)

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.